Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Serina Therapeutics (SER) has provided an announcement.
Tacey Viegas, the Chief Operating Officer of Serina Therapeutics, Inc., is set to retire on July 15, 2024. Upon his departure, he will receive his base salary and additional monthly compensation for a year, alongside a consulting agreement with the company to work on various projects. This agreement also extends the term of his stock options, reinforcing his ongoing connection with the company’s financial interests.
Find detailed analytics on SER stock on TipRanks’ Stock Analysis page.